A new device to help pregnant women with cervical insufficiency

Who could benefit from this research

What this research studies

This research focuses on developing a novel medical device designed to assist pregnant women suffering from cervical insufficiency, a condition that can lead to preterm birth. The device, known as the Cx Device, aims to enhance the effectiveness of the existing surgical treatment called cervical cerclage, which involves placing a suture around the cervix to prevent premature dilation. By using a unique design with silicone plates, the device seeks to improve outcomes and reduce potential complications associated with traditional cerclage procedures. The research will involve testing the device's safety and efficacy in clinical settings to ensure it provides better support for women at risk of preterm birth.

Why it matters

Where this research is happening

• Cx Therapeutics, INC
  Lexington, United States Active

Researchers

• Principal investigator: House, Michael Douglas — Cx Therapeutics, INC
• Study coordinator: House, Michael Douglas

Related research

Other NIH-funded projects on the same topics.

• Choline for fetal brain protection in pregnant women who drink heavily

  Giving choline to pregnant women who drink heavily may help protect the baby’s brain and improve early development.

  NIH research Massachusetts General Hospital · Boston, United States · NIH-11616489

• Mentor Moms+: a community-led plan to cut alcohol use and HIV risk during pregnancy in South Africa

  A community-based program adapts a trusted peer-led model to help pregnant and lactating people reduce alcohol use and HIV risk in South Africa.

  NIH research University of California Los Angeles · Los Angeles, United States · NIH-11612340

• Smartphone app helps pregnant women in Ghana monitor blood pressure at home

  A smartphone app is being customized for pregnant women in Ghana to support home blood pressure monitoring and improve safety during pregnancy.

  NIH research University of Michigan at Ann Arbor · Ann Arbor, United States · NIH-11607773

• Game-based mobile app to help pregnant women with overweight/obesity manage weight in Nepal

  A new app designed for pregnant women in Nepal with overweight or obesity to help manage weight gain during pregnancy and reduce weight retention after birth.

  NIH research Rutgers Biomedical and Health Sciences · Newark, UNITED STATES · NIH-11601016

• Integrated biomarker study of metabolic syndrome in pregnant women with HIV on DTG-based ART

  Researchers will look for biological signs in pregnant women with HIV on a DTG-based regimen to understand why weight gain and metabolic problems happen and how these affect pregnancy.

  NIH research Johns Hopkins University · Baltimore, United States · NIH-11593952

• Biomarker profiling to understand metabolic syndrome in pregnant women with HIV on DTG-based ART

  This project looks at why some pregnant women living with HIV on a common DTG-based therapy gain weight or develop metabolic problems, by studying their proteins and metabolites across four sites in the US and Nigeria.

  NIH research Johns Hopkins University · Baltimore, United States · NIH-11593951

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.